Loiselle, Allison R.
Johnson, Jessica K.
Thibau, Isabelle J.
Smith Begolka, Wendy
Funding for this research was provided by:
National Eczema Association
Article History
Received: 30 May 2024
Revised: 8 January 2025
Accepted: 27 January 2025
First Online: 10 February 2025
Declarations
:
: This study was identified as exempt by the Western Institutional Review Board Copernicus Group under 45 CFR ยงย 46.104(d)(2), because the research only included survey procedures with adequate measures to protect the privacy and confidentiality of participants. Prior to completing the online survey, all respondents provided electronic informed consent. Data were anonymized for analysis and treated confidentially. All methods were carried out according to the Declaration of Helsinki.
: ARL, JK and IT work for the National Eczema Association, but have no other relevant disclosures. WSB has served as an advisory board member for Pfizer and Amgen, received honoraria and research grants, and served as a Pfizer investigator.